Evidence map›Paper›PMID 36223373›Full record

ArticlePloS one2022

Using ISARIC 4C mortality score to predict dynamic changes in mortality risk in COVID-19 patients during hospital admission.

Tim Crocker-Buque, Jonathan Myles, Adam Brentnall, Rhian Gabe, Stephen Duffy, Sophie Williams, Simon Tiberi

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. The SpOJournal of clinical medicine · 2024
    Article
  4. Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tim Crocker-BuqueThe Royal London Hospital, Barts Health NHS Trust, Whitechapel, London, United Kingdom.ORCID 0000-0003-0059-7735
Jonathan MylesWolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.
Adam BrentnallWolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.
Rhian GabeWolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.
Stephen DuffyWolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.
Sophie WilliamsThe Royal London Hospital, Barts Health NHS Trust, Whitechapel, London, United Kingdom.ORCID 0000-0003-0266-5084
Simon TiberiThe Royal London Hospital, Barts Health NHS Trust, Whitechapel, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As SARS-CoV-2 infections continue to cause hospital admissions around the world, there is a continued need to accurately assess those at highest risk of death to guide resource use and clinical management. The ISARIC 4C mortality score provides mortality risk prediction at admission to hospital based on demographic and physiological parameters. Here we evaluate dynamic use of the 4C score at different points following admission. Score components were extracted for 6,373 patients admitted to Barts Health NHS Trust hospitals between 1st August 2020 and 19th July 2021 and total score calculated every 48 hours for 28 days. Area under the receiver operating characteristic (AUC) statistics were used to evaluate discrimination of the score at admission and subsequent inpatient days. Patients who were still in hospital at day 6 were more likely to die if they had a higher score at day 6 than others also still in hospital who had the same score at admission. Discrimination of dynamic scoring in those still in hospital was superior with the area under the curve 0.71 (95% CI 0.69-0.74) at admission and 0.82 (0.80-0.85) by day 8. Clinically useful changes in the dynamic parts of the score are unlikely to be associated with subject-level measurements. Dynamic use of the ISARIC 4C score is likely to provide accurate and timely information on mortality risk during a patient's hospital admission.

Indexed as

COVID-19Cohort StudiesHospital MortalityHospitalsHumansRetrospective StudiesRisk AssessmentSARS-CoV-2

Identifiers

PMID36223373
PMCPMC9555674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.